[go: up one dir, main page]

PE20081892A1 - Nuevos analogos de amino-piridina como agentes antitromboticos - Google Patents

Nuevos analogos de amino-piridina como agentes antitromboticos

Info

Publication number
PE20081892A1
PE20081892A1 PE2008000132A PE2008000132A PE20081892A1 PE 20081892 A1 PE20081892 A1 PE 20081892A1 PE 2008000132 A PE2008000132 A PE 2008000132A PE 2008000132 A PE2008000132 A PE 2008000132A PE 20081892 A1 PE20081892 A1 PE 20081892A1
Authority
PE
Peru
Prior art keywords
alkyl
antithrombotic agents
alkyltio
cyane
oxopyrrolidin
Prior art date
Application number
PE2008000132A
Other languages
English (en)
Inventor
Kosrat Amin
Thomas Antonsson
Christoffer Bengtsson
Ruth Bylund
Daniel Hovdal
Johan Johansson
David Brown
Fabrizio Giordanetto
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40253667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081892(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20081892A1 publication Critical patent/PE20081892A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO ANALOGOS DE PIRIDINA DE FORMULA (I), EN EL QUE R1 ES R7C(O), R17S, R18C(S), ENTRE OTROS; R7 ES ALQUILO C1-C12, ALQUENILO C2-C12, ARILO, HETEROCICLIL(C1-C12)ALQUILSULFONILO, ENTRE OTROS; R17 Y R18 SON CADA UNO ALQUILO C1-C12, HIDROXI(C1-C12)ALQUILO, HETEROCICLILO, ENTRE OTROS; R2 ES C1-C12 ALQUILO, C1-C12 ALCOXI, C1-C12 ALQUILTIO, ENTRE OTROS; R3 ES H, CN, NO2, HETEROCICLIL(C1-C12)ALQUILSULFINILO, ENTRE OTROS; R4 ES NO2, F, C1-C12 ALQUILTIO, ENTRE OTROS; R5 ES H, C1-C12 ALQUILO, CARBOXI(C1-C6)ALQUILO; R14 Y R15 SON CADA UNO H, OH; Rc ES C1-C4 OXOALQUILENO, C2-C4 ALQUINILO, ENTRE OTROS; Rd ES C1-C12 ALQUILO, C3-C8 CICLOALQUILO, ARILO O HETEROARILO; X ES UN ENLACE SIMPLE IMINO(-NH-), METILENO(-CH2-), ENTRE OTROS; Y B ES UN SISTEMA DE ANILLOS DE 4 A 11 MIEMBROS, QUE CONTIENE N, O, S. SON SELECCIONADOS: 1-{5-ACETIL-3-CIANO-6-[(2-OXOPIRROLIDIN-1-IL)METIL]PIRIDIN-2-IL}-N-(BENCILSULFONIL)PIPERIDIN-4-CARBOXAMIDA; N-(BENCILSULFONIL)-1-{5-BUTIRIL-3-CIANO-6-[(2-OXOPIRROLIDIN-1-IL)METIL]PIRIDIN-2-IL}PIPERIDIN-4-CARBOXAMIDA; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES REVERSIBLES DE P2Y12, UTILES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES Y/O COMO AGENTES ANTITROMBOTICOS
PE2008000132A 2007-07-13 2008-01-11 Nuevos analogos de amino-piridina como agentes antitromboticos PE20081892A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94968707P 2007-07-13 2007-07-13

Publications (1)

Publication Number Publication Date
PE20081892A1 true PE20081892A1 (es) 2009-02-21

Family

ID=40253667

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000132A PE20081892A1 (es) 2007-07-13 2008-01-11 Nuevos analogos de amino-piridina como agentes antitromboticos

Country Status (7)

Country Link
US (1) US20090018166A1 (es)
AR (1) AR064865A1 (es)
CL (1) CL2008000090A1 (es)
PE (1) PE20081892A1 (es)
TW (1) TW200902513A (es)
UY (1) UY30865A1 (es)
WO (1) WO2009011627A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080009523A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New Pyridine Analogues IV
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
MY194204A (en) 2014-08-04 2022-11-21 Nuevolution As Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
CN105847191B (zh) * 2016-03-23 2019-03-01 华为技术有限公司 一种基于重排序算法的交换设备
WO2021124277A1 (en) 2019-12-20 2021-06-24 Nuevolution A/S Compounds active towards nuclear receptors
US11685727B2 (en) 2019-12-20 2023-06-27 Nuevolution A/S Compounds active towards nuclear receptors
CA3174176A1 (en) 2020-03-31 2021-10-07 Sanne Schroder Glad Compounds active towards nuclear receptors
AU2021245397A1 (en) 2020-03-31 2022-10-20 Nuevolution A/S Compounds active towards nuclear receptors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
CA2400479C (en) * 2000-02-04 2010-10-05 Millennium Pharmaceuticals, Inc. Platelet adp receptor inhibitors
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
WO2003022214A2 (en) * 2001-09-06 2003-03-20 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
JP4879745B2 (ja) * 2003-10-03 2012-02-22 ポートラ ファーマシューティカルズ， インコーポレイテッド 置換イソキノリノン
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
BRPI0512535A (pt) * 2004-06-24 2008-03-25 Incyte Corp compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
EP1836189A1 (en) * 2005-01-06 2007-09-26 AstraZeneca AB Novel pyridine compounds
MX2008000470A (es) * 2005-07-13 2008-03-11 Astrazeneca Ab Analogos de piridina nuevos.
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
US20080009523A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New Pyridine Analogues IV
JP2009542643A (ja) * 2006-07-04 2009-12-03 アストラゼネカ アクチボラグ 新規ピリジン類似体
MX2008016557A (es) * 2006-07-04 2009-02-06 Astrazeneca Ab Analogos de piridina nuevos.

Also Published As

Publication number Publication date
CL2008000090A1 (es) 2009-01-16
UY30865A1 (es) 2009-03-02
AR064865A1 (es) 2009-04-29
US20090018166A1 (en) 2009-01-15
WO2009011627A1 (en) 2009-01-22
TW200902513A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
PE20081892A1 (es) Nuevos analogos de amino-piridina como agentes antitromboticos
AR077505A1 (es) Compuestos de piridina y sus usos
AR083070A1 (es) Analogos de nucleotidos sustituidos con heterociclos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales, en particular infecciones por vhc
AR062409A1 (es) Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto
PE20201165A1 (es) Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
DOP2010000046A (es) Compuestos de biciclolactama sustituida
AR049399A1 (es) Difenilimidazopirimidina e -imidazol aminas como inhibidores de b-secretasa y metodo de obtencion de los mismos
PE20141352A1 (es) Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento
AR084768A1 (es) Moduladores de la senda de complemento y usos de los mismos
AR056536A1 (es) Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace)
AR063684A1 (es) Derivados de 4, 4´-bifenildiilbis(1h-imidazol-5, 2-diil) como inhibidores del virus de la hepatitis c, composicion que los comprende y su uso para tratar una infeccion con vhc.
PE20080275A1 (es) Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa
ES2328820T3 (es) Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer.
AR053195A1 (es) Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo
AR079550A1 (es) Derivados de pirazol
PE20160751A1 (es) Moduladores de tetrahidropiridopirazinas de gpr6
CO6460743A2 (es) Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica
PE20051094A1 (es) Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico y procesos para su preparacion
CO6020016A1 (es) Derivados de 1,2,4,5 tetrahidro-3h-benzapezinas su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PE20090307A1 (es) Derivados de 7-alquinil-1,8-naftiridonas como agentes inhibidores de vegfr-3
AR073043A1 (es) Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras.
ECSP099216A (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR079448A1 (es) Inhibidores de la esfingosina quinasa
AR062737A1 (es) Composicion farmaceutica que comprende un compuesto derivado de aril-azabiciclo, compuesto correspondiente y su uso para la preparacion de un medicamento
AR059018A1 (es) Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k

Legal Events

Date Code Title Description
FA Abandonment or withdrawal